2021 年上半年，韩国医药和生物技术出口增长 55%，达到 32.6 亿美元。 South Korea's pharmaceutical & biotech exports increased 55% in H1 2021, reaching $3.26B.

2021 年上半年，韩国医药和生物技术出口激增 55%，达到 32.6 亿美元，而 2020 年上半年为 20.9 亿美元，尽管出口交易数量从 12 笔减少到 7 笔。 South Korea's pharmaceutical & biotech exports surged 55% in H1 2021, reaching $3.26B compared to $2.09B in H1 2020, despite a drop in export deals from 12 to 7. 韩国制药与生物制药制造商协会预计年总额将达到 8 万亿韩元。 The Korea Pharmaceutical & Bio-Pharma Manufacturers Association expects the annual total to reach 8 trillion won. 该官员指出，韩国制药和生物制药技术竞争力的提高是增长的动力。 The official cited improved competitiveness of South Korea's pharmaceutical & biopharmaceutical technologies as the growth driver.